Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19216625rdf:typepubmed:Citationlld:pubmed
pubmed-article:19216625lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:19216625lifeskim:mentionsumls-concept:C0011849lld:lifeskim
pubmed-article:19216625lifeskim:mentionsumls-concept:C0205112lld:lifeskim
pubmed-article:19216625lifeskim:mentionsumls-concept:C1313386lld:lifeskim
pubmed-article:19216625lifeskim:mentionsumls-concept:C1511237lld:lifeskim
pubmed-article:19216625lifeskim:mentionsumls-concept:C1705509lld:lifeskim
pubmed-article:19216625lifeskim:mentionsumls-concept:C1879746lld:lifeskim
pubmed-article:19216625lifeskim:mentionsumls-concept:C1547011lld:lifeskim
pubmed-article:19216625lifeskim:mentionsumls-concept:C1550436lld:lifeskim
pubmed-article:19216625pubmed:issue3lld:pubmed
pubmed-article:19216625pubmed:dateCreated2009-2-16lld:pubmed
pubmed-article:19216625pubmed:abstractTextThe prevalence of diabetes mellitus continues to increase throughout the world with an expected doubling of documented cases between 2006 and 2030, diabetes deaths are expected to increase by more than 50% from 2006 to 2015. Therapeutic interventions should be based on scientific evidence, including earlier insulin initiation and use of a basal-bolus approach that better mimics normal physiology.lld:pubmed
pubmed-article:19216625pubmed:languageenglld:pubmed
pubmed-article:19216625pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19216625pubmed:citationSubsetIMlld:pubmed
pubmed-article:19216625pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19216625pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19216625pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19216625pubmed:statusMEDLINElld:pubmed
pubmed-article:19216625pubmed:monthMarlld:pubmed
pubmed-article:19216625pubmed:issn1744-7682lld:pubmed
pubmed-article:19216625pubmed:authorpubmed-author:IltzJason LJLlld:pubmed
pubmed-article:19216625pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19216625pubmed:volume9lld:pubmed
pubmed-article:19216625pubmed:ownerNLMlld:pubmed
pubmed-article:19216625pubmed:authorsCompleteYlld:pubmed
pubmed-article:19216625pubmed:pagination369-75lld:pubmed
pubmed-article:19216625pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:19216625pubmed:meshHeadingpubmed-meshheading:19216625...lld:pubmed
pubmed-article:19216625pubmed:meshHeadingpubmed-meshheading:19216625...lld:pubmed
pubmed-article:19216625pubmed:meshHeadingpubmed-meshheading:19216625...lld:pubmed
pubmed-article:19216625pubmed:meshHeadingpubmed-meshheading:19216625...lld:pubmed
pubmed-article:19216625pubmed:meshHeadingpubmed-meshheading:19216625...lld:pubmed
pubmed-article:19216625pubmed:meshHeadingpubmed-meshheading:19216625...lld:pubmed
pubmed-article:19216625pubmed:year2009lld:pubmed
pubmed-article:19216625pubmed:articleTitleInsulin glulisine: aspects of basal/bolus therapy for optimized treatment of diabetes mellitus.lld:pubmed
pubmed-article:19216625pubmed:affiliationDepartment of Pharmacotherapy, Washington State University, College of Pharmacy, PO Box 1495, Spokane, WA 99210-1495, USA. iltzj@wsu.edulld:pubmed
pubmed-article:19216625pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19216625pubmed:publicationTypeReviewlld:pubmed